Policy Statement Updates Guidelines on Pediatric Drowning Prevention
Medically reviewed by Drugs.com
via HealthDayMONDAY, May 18, 2026 -- Multiple layers of drowning prevention should be emphasized by pediatricians, according to a policy statement and accompanying technical report published online May 18 in Pediatrics.
Rohit P. Shenoi, M.D., from the Baylor College of Medicine and Texas Children's Hospital in Houston, and colleagues developed a policy statement to guide clinicians, parents and caregivers, community partners, injury-prevention professionals, and policymakers regarding evidence-based best practices for reducing pediatric drowning.
The guidelines for pediatricians focus on providing all parents with drowning-prevention anticipatory guidance, based on child age, drowning risk, and water exposure. Multiple layers of drowning prevention should be emphasized, and barriers limiting their use should be inquired about. These layers include warning about high-risk settings; emphasizing the need for a four-sided fence with a self-closing, self-latching gate for residential pools; swimming in designated safe and lifeguarded areas; defining supervision as close, constant, attentive, and competent; use of life jackets; and emphasis of water competency for the entire family. Children at higher risk for drowning due to age, comorbidities, exposure, or lack of aquatic experience and swimming ability should be identified, and evidence-based countermeasures should be recommended to mitigate risk. Aquatic experiences are recommended for infants with a parent, and swimming lessons are recommended after the first birthday. Families of children with disabilities should be encouraged to seek the benefits of swimming or water recreation programs.
"Preventing drowning is not the responsibility of families alone," Shenoi said in a statement. "This is a team effort, and pediatricians are in an excellent position to help raise awareness with patients and community partners."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-19 09:50
Read more
- Launch of 988 Lifeline Tied to Drop in Suicides in Teens, Young Adults
- Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
- Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the First and Only Approved Medicine for Focal Segmental Glomerulosclerosis (FSGS)
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions